LW RX Wins Ro Dropped Compounded Semaglutide: After the FDA resolved the semaglutide shortage in February 2025, Ro pivoted to brand-name only medications (Wegovy/Zepbound), dramatically increasing patient costs
Some patients are happy with their progress but still want help with: That does not necessarily mean GLP-1 treatment failed
Appetite Suppressants and Energy Boosters For those struggling with hunger or fatigue during their weight loss journey, we offer customized solutions to keep you on track: Low-Dose Naltrexone (LDN) : To help manage cravings and support overall well-being
obesity trial: cardiometabolic markers, liver fat reduction, lipid profiles Hepatology (2024) Triple agonists in NAFLD/NASH: hepatic steatosis resolution (preclinical and clinical evidence) The Lancet (2023) Supplementary Data Rosenstock et al
ProCare Wellness Institute welcomes Savannah men to the new era in erectile dysfunction treatments
Does PSPeptides accept Afterpay